FCPA In The China Framework Warrants Special Attention
This article was originally published in PharmAsia News
Executive Summary
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?